Anokion anokion.com

Anokion, a spin-off from the Ecole Polytechnique Federale de Lausanne (EPFL), is focused on applying the company's antigen-specific immune tolerance technology to treat autoimmune and allergic diseases and reduce the immunogenicity of therapeutic proteins. As a platform technology, Anokion's approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications.

Anokion, a spin-off from the Ecole Polytechnique Federale de Lausanne (EPFL), is focused on applying the company's antigen-specific immune tolerance technology to treat autoimmune and allergic diseases and reduce the immunogenicity of therapeutic pro...Show all

See All Exits Recent Exits

Phone: +41 21 693 72 37

Fax:

EPFL Innovation Park-L
Chemin de la Dent d’Oche 1A
Ecublens, CH-1024
Switzerland

Anokion - Investments & Acquisitions

Show Real Data Anokion Investments
See all Recent Investments
Date Company Round Amount Co-investors
See all 0 investments